Wegovy

• Wegovy won’t be in Canadian public drug plans as Novo Nordisk refuses talks

  Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving forward.

  Health

  Dec 3
  
• Ozempic, Wegovy makers Novo Nordisk announce 9K layoffs in restructuring

  Ozempic and Wegovy maker Novo Nordisk says it will layoff about 9,000 employees of its global workforce as it restructures in an attempt to fend off competition.

  World

  Sep 10
  
• Advertisement
• University of Manitoba studies Ozempic marketing

  Researchers at the University of Manitoba are looking at how marketing for drugs like Ozempic and Wegovy influence peoples' views on food, hunger, and weight.

  Health

  Jul 23
• Advertisement
• Ozempic, Wegovy linked to rare cases of eye disorder, EMA says

  Called non-arteritic anterior ischemic optic neuropathy (NAION), the condition may affect up to 1 in 10,000 people taking semaglutide.

  Consumer

  Jun 6
• Weight-loss drug Wegovy use is up 50% among U.S. teens, study shows

  A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

  Health

  Jun 3
• Drugs like Ozempic may lower cancer risk if you have diabetes: study

  Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether drugs like Wegovy, Ozempic and Zepbound could play a role in cancer prevention.

  Health

  May 23
• Zepbound beats Wegovy rival in 1st head-to-head weight loss study

  People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.

  Health

  May 12
• Ozempic, Wegovy shortages are resolved in the U.S.: FDA

  The drugmaker Novo Nordisk can meet present and future demand in the U.S. for its drugs including Ozempic and Wegovy, the U.S. Food and Drug Administration said.

  Health

  Feb 21
• Advertisement
• Wegovy approved in Canada to combat risk of non fatal-heart attack

  Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.

  Health

  Nov 27, 2024
• Advertisement
• Biden proposes coverage for weight-loss drugs for millions of obese Americans

  While the rule would give millions of people access to weekly injectables that have helped people shed pounds, it would cost taxpayers as much as $35 billion over the next decade.

  Health

  Nov 26, 2024